Lassmann, Hans
Targeting intracerebral inflammation in multiple sclerosis: is it feasible? [electronic resource]
- Acta neuropathologica Sep 2012
- 395-6 p. digital
Publication Type: Journal Article; Comment
1432-0533
10.1007/s00401-012-1015-3 doi
Animals
Astrocytes--drug effects
Blood-Brain Barrier--drug effects
Ceramides--metabolism
Demyelinating Diseases--prevention & control
Female
Fingolimod Hydrochloride
Humans
Immunosuppressive Agents--pharmacology
Male
Multiple Sclerosis--physiopathology
NF-kappa B--metabolism
Oligodendroglia--drug effects
Propylene Glycols--pharmacology
Quinolones--pharmacology
Sphingosine--analogs & derivatives